bims-matara Biomed News
on MTOR
Issue of 2026–11–15
seventeen papers selected by
Lucas van Endert, Institut du Cerveau and Alisa Kirkin, Université de Fribourg



  1. Cell Signal. 2026 Nov 12. pii: S0898-6568(26)00669-8. [Epub ahead of print] 113009
      The mechanistic target of rapamycin (mTOR) coordinates cell growth, metabolism, protein synthesis, autophagy, and survival by integrating nutrient availability, growth factors, energy status, mechanical cues, and cellular stress. Beyond classical biochemical cascades, mTOR signaling specificity is fundamentally governed by subcellular localization, temporal recruitment, and microenvironmental context. This review synthesizes current insights into the spatial architecture of mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2) across lysosomes, endosomes, plasma-membrane microdomains, organelle contact sites, neuronal processes, the nucleus, and biomolecular condensates. We examine how physical principles-including membrane composition and curvature, molecular confinement, macromolecular crowding, scaffold-mediated multivalent interactions, organelle positioning, mechanical tension, and localized translation-dictate signaling outcomes. Furthermore, we contrast membrane-anchored molecular assemblies with three-dimensional biomolecular condensates, detailing their interplay during stress adaptation. Spatial constraints in specialized cell geometries, such as neuronal compartments and developing tissues, illustrate how identical signaling machinery yields divergent functional outputs under altered diffusion environments. We also evaluate how advances in spatial multi-omics and super-resolution imaging extend these subcellular paradigms to tissue-scale heterogeneity. Finally, we highlight major translational hurdles, including the trade-off between spatial resolution and dynamic temporal tracking in current technologies, as well as the inability of conventional pharmacotherapies to selectively target discrete subcellular mTOR pools. Establishing spatial organization as a primary determinant of mTOR signaling clarifies context-dependent physiological outputs and provides a roadmap for developing next-generation spatially targeted therapeutics.
    Keywords:  Biomolecular condensates; Localized translation; Mechanistic target of rapamycin (mTOR); Membrane microdomains; Metabolic signaling; Spatial regulation; Subcellular compartmentalization
    DOI:  https://doi.org/10.1016/j.cellsig.2026.113009
  2. Biophys J. 2026 Nov 09. pii: S0006-3495(26)00760-5. [Epub ahead of print]
      Long noncoding RNAs, previously thought to serve no function, have recently been discovered to encode for microproteins that regulate cellular functions. Small regulatory peptide of amino acid response (SPAR) is a microprotein in the lysosome that responds to amino acid availability in the cell. In this study, we investigated the interactions between SPAR and SLC38A9, a lysosomal amino acid transporter and receptor involved in the mechanistic target of rapamycin 1 (mTORC1) pathway. We found that SPAR binds SLC38A9 and inhibits arginine transport in SLC38A9. Moreover, the downstream recruitment of Rag GTPases is also inhibited when SPAR is present in SLC38A9 liposomes. The docking model shows potential interactions between SPAR and SLC38A9. Together, these findings reveal the mechanism of mTORC1 inhibition through microprotein SPAR and illustrate the power of non long coding RNAs in altering cellular functions.
    DOI:  https://doi.org/10.1016/j.bpj.2026.11.009
  3. Front Pharmacol. 2026 ;17 1994231
      Despite advances in lipid lowering, anti-inflammatory therapy and revascularization, residual cardiovascular risk may partly reflect persistent lesion-level inflammation and defective plaque repair that are not fully corrected by systemic risk-factor control. The mechanistic target of rapamycin (mTOR) integrates inflammatory, metabolic and reparative programmes, but its effects vary with cell state, plaque niche, complex identity, and signalling amplitude and duration. Evidence is strongest for context-dependent macrophage mTOR signalling, yet macrophage/myeloid mTORC2 disruption has produced opposing lesion phenotypes across genetic models; endothelial and smooth-muscle evidence remains less direct. Pharmacological, genetic and lesion-directed delivery studies demonstrate that mTOR perturbation can modify experimental atherosclerosis. However, genetic perturbation cannot be equated with rapalog pharmacology, and existing studies do not yet define cell-resolved exposure-engagement-response relationships and relate them to plaque composition. This evidential asymmetry limits interpretation of whether broad or prolonged mTOR inhibition can selectively suppress disease-amplifying outputs while preserving homeostatic programmes. In this Review, focused primarily on lipid-rich, rupture-prone plaques and using rapalogs as the principal pharmacological model, we apply an exposure-guided pharmacological framework to distinguish administered dose from lesion exposure, cellular availability, target engagement and pharmacodynamic recovery. Compartment-resolved PK-PD studies, cell-specific pathway interrogation and large-animal validation will be needed to quantify these relationships and determine whether maladaptive mTOR outputs can be suppressed without compromising vascular repair.
    Keywords:  atherosclerosis; lesion-directed drug delivery; mTOR signalling; pharmacokinetics–pharmacodynamics; plaque stability; rapalogs; target engagement
    DOI:  https://doi.org/10.3389/fphar.2026.1994231
  4. Cells. 2026 Oct 31. pii: 1997. [Epub ahead of print]15(21):
      PTEN loss activates PI3K-AKT signaling, and mTORC1 stimulates pyrimidine synthesis through S6K1-mediated CAD phosphorylation. This exploratory public-data analysis tested whether PTEN deletion in primary prostate cancer is associated with CAD, mTORC1 and pyrimidine-synthesis expression, and whether these survive protein-level and confounder analyses. In 485 primary tumors from The Cancer Genome Atlas Prostate Adenocarcinoma (TCGA-PRAD; 159 PTEN-deleted), deletion was associated with higher CAD mRNA (Hedges' g = 0.57) and higher Hallmark mTORC1 scores (g = 0.54). In 342 tumors with reverse-phase protein-array data, deletion was accompanied by lower PTEN protein and higher AKT Ser473 phosphorylation but not by a higher pre-specified mTORC1 phospho-output composite (g = -0.02), itself uncorrelated with the transcriptional score. In a pre-specified model adding purity, TP53, RB1, ERG fusion and batch (n = 276), the PTEN-CAD association was absent (β = -0.002; p = 0.96), whereas the mTORC1-score association persisted. In a post hoc decomposition, ERG fusion, which co-occurs with PTEN deletion (odds ratio 3.6), changed the coefficient most. Across eight cohorts, a small PTEN mRNA-CAD association (g = 0.23) was attenuated to 0.14 after ERG adjustment, with overlapping confidence intervals (Hartung-Knapp p = 0.071). Bulk-tumor pathway signatures and PTEN-CAD associations need protein-level and ERG-aware interpretation.
    Keywords:  CAD; ERG fusion; PTEN; TCGA-PRAD; confounding; de novo pyrimidine synthesis; mTORC1; meta-analysis; prostate cancer; reverse-phase protein array
    DOI:  https://doi.org/10.3390/cells15211997
  5. Cells. 2026 Oct 31. pii: 1998. [Epub ahead of print]15(21):
      Glioma is the most prevalent and aggressive brain tumor with high recurrence rates and poor survival. Porphyromonas gingivalis (P. gingivalis), a major periodontal pathogen, has emerged as a potential contributor to neurological diseases. However, whether P. gingivalis is present in glioma tissues and directly promotes malignant progression remains unclear. Here, immunohistochemistry the detected gingipain in 11 of 13 human glioma specimens, while fluorescence in situ hybridization further detected P. gingivalis-targeted 16S rRNA signals in 3 of 13 specimens. These findings support the presence of P. gingivalis-associated signals in human glioma tissues. In cellular models, P. gingivalis invaded glioblastoma cells and promoted cell proliferation, migration, and invasion through induction of mesenchymal transition and extracellular matrix remodeling, thereby accelerating glioma progression. In a mouse xenograft model, P. gingivalis inoculation enhanced tumor growth and was associated with changes in proliferation, mesenchymal transition, and ECM remodeling-related markers. Mechanistically, P. gingivalis activated the PI3K/AKT/mTOR signaling pathway, while pharmacological AKT inhibition (AKTi-1/2) effectively suppressed these tumor-promoting effects. Metronidazole treatment also reduced tumor growth in vivo. Collectively, these findings identify P. gingivalis as a potential microbial contributor to glioma malignant progression and support further investigation of host-microbe interactions and AKT signaling as potential avenues for therapeutic research.
    Keywords:  PI3K/AKT/mTOR pathway; Porphyromonas gingivalis; glioma; tumor progression
    DOI:  https://doi.org/10.3390/cells15211998
  6. Int J Mol Sci. 2026 Nov 07. pii: 9996. [Epub ahead of print]27(21):
      Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal cancer with poor prognosis due to chemoresistance and limited treatment options. Schisandrin B (Sch B), a bioactive compound from Schisandra chinensis, has demonstrated anticancer effects in various malignancies, but its role in PDAC remains unknown. This study explores the antitumor mechanisms of Sch B using network pharmacology, molecular docking, and in vitro and in vivo experiments, focusing on the EGFR/AKT/mTOR signaling pathway and mitochondrial dysfunction. Network pharmacology identified EGFR, CASP3, BCL2, and HSP90 as key candidate targets of Sch B, and molecular docking and MD simulation were used to explore putative interactions with these proteins. In PDAC cells, treatment Sch B for 48 h reduced cell viability. In addition, Sch B suppressed EGFR/AKT/mTOR signaling and induced mitochondrial dysfunction, characterized by loss of mitochondrial membrane potential, increased mitochondrial and cytosolic calcium levels, and elevated ROS production, accompanied by activation of apoptotic signaling. Co-treatment with gemcitabine demonstrated enhanced effects, elevating apoptosis and oxidative stress. Moreover, Sch B significantly reduced tumor growth in a PANC-1 xenograft model, accompanied by decreased protein expression of EGFR, AKT, mTOR, and HSP90 in tumor tissues. These findings suggest that Sch B exerts antitumor activity associated with modulation of EGFR/AKT/mTOR signaling and mitochondrial dysfunction, supporting further investigation of Sch B as a potential therapeutic candidate for PDAC, particularly in combination with standard chemotherapy.
    Keywords:  EGFR; MD simulation; mitochondrial dysfunction; network pharmacology; pancreatic ductal adenocarcinoma; schisandrin B
    DOI:  https://doi.org/10.3390/ijms27219996
  7. Genes Cells. 2026 Nov;pii: e70155. [Epub ahead of print]31(6):
      Phosphatase and tensin homolog (PTEN) is a tumor suppressor that helps maintain genomic integrity, particularly through its nuclear functions. Although PTEN is distributed throughout the cell under normal conditions, it translocates to the nucleus following DNA damage. The Ser380/Thr382/Thr383/Ser385 (STTS) cluster is critical for subcellular localization; however, its detailed regulatory mechanisms remain unclear. In the present study, aspartic acid 386 (Asp386) was identified as a novel determinant of PTEN subcellular localization. PTEN fragmentation experiments indicated that residue 386 is critical for subcellular localization. The D386R (Asp386-to-Arg) variant exhibited nuclear accumulation comparable to that of the A4 (STTS-to-alanine) variant, and the double mutant exhibited a similar level of nuclear accumulation. Consistent with the requirement of Lys13 ubiquitination for nuclear import, the related double mutants PTENK13R,A4 and PTENK13R,D386R exhibited comparable plasma membrane localization, while the triple mutant PTENK13R,A4,D386R also showed no significant difference in plasma membrane localization. Furthermore, western blot analysis revealed that the D386R mutation reduced Ser380/Thr382/Thr383 phosphorylation. These findings suggest that an acidic residue at position 386 is important for efficient phosphorylation of the STTS cluster and cytoplasmic retention of PTEN.
    Keywords:  PTEN; amino acid polarity; asp386; nuclear translocation
    DOI:  https://doi.org/10.1111/gtc.70155
  8. Neuroscience. 2026 Nov 11. pii: S0306-4522(26)00740-2. [Epub ahead of print]
      Alzheimer's disease (AD), the leading cause of dementia, is increasingly recognized as a metabolic disorder characterized by disrupted insulin and insulin-like growth factor-1 signaling in the brain, a concept now referred to as type 3 diabetes. Central to this perspective is the insulin receptor substrate-1/phosphoinositide 3-kinase/protein kinase B/mechanistic target of rapamycin (IRS-1/PI3K/Akt/mTOR) cascade, which acts as the primary convergence point linking systemic insulin resistance to neurodegeneration. Impaired insulin signaling in astrocytes, neurons, microglia, and cerebral endothelial cells disrupts glucose metabolism, energy production, and amyloid-β (Aβ) clearance, while promoting tau hyperphosphorylation through glycogen synthase kinase-3β activation. Chronic mTOR hyperactivation exacerbates these dysfunctions by suppressing autophagy, impairing insulin sensitivity, and compromising blood-brain barrier (BBB) integrity through tight junction disassembly, pericyte loss, and endothelial senescence. These processes collectively establish a self-perpetuating cycle of metabolic dysfunction, protein aggregation, neuroinflammation, and vascular breakdown. Neuron-derived extracellular vesicles have emerged as a promising non-invasive biomarker platform for monitoring central insulin resistance and therapeutic response in real time. Metabolically targeted interventions, including intranasal insulin, glucagon-like peptide-1 receptor agonists, and mTOR inhibitors such as rapamycin, demonstrate encouraging preclinical and early clinical efficacy in restoring insulin sensitivity, reducing tau and Aβ pathology, and preserving BBB function. However, challenges related to delivery and dosing remain significant barriers to clinical translation. Continued investigation into neurovascular unit and multi-target combination therapies may facilitate the development of effective, biomarker-guided treatments for AD.
    Keywords:  Alzheimer’s disease; Brain insulin resistance; Neurovascular unit; Type3diabetes; mTOR signaling
    DOI:  https://doi.org/10.1016/j.neuroscience.2026.11.018
  9. JCI Insight. 2026 Nov 09. pii: e207890. [Epub ahead of print]11(21):
      Cellular senescence, a hallmark of aging, is accompanied by a striking expansion of the cell's lysosomal compartment, yet the pathway leading to increased lysosomal content remains unresolved. Here, we demonstrate that the master lysosomal transcriptional regulator TFEB is activated during senescence through a pathway that involves conjugation of ATG8 onto single membranes (CASM). Using various senescence inducers, we show that senescence induction triggers robust TFEB nuclear translocation and upregulation of TFEB target genes. In contrast, inhibition of the core CASM machinery by CRISPR-mediated deletion of either ATG16L1, ATG12, or ATG5 markedly reduced senescence-induced TFEB nuclear translocation. In ATG16L1-KO cells, reconstitution with WT ATG16L1 but not the CASM-defective ATG16L1F467A mutant restored both ATG8 lipidation on the lysosomal surface and TFEB activation. Moreover, expression of the Salmonella effector protein SopF, a previously described specific CASM inhibitor, similarly blocked senescence-induced TFEB translocation. Functionally, upon stress, CASM-deficient cells exhibited a pronounced shift away from senescence and toward a cell death fate, a phenotype reversed by expressing a constitutively active form of TFEB. Together, these findings identify CASM-dependent TFEB activation as an essential mechanism enabling senescence-associated lysosomal expansion and suggest that lysosomal capacity modulates cell fate decisions in the aftermath of acute stress.
    Keywords:  Aging; Cell biology; Lysosomes
    DOI:  https://doi.org/10.1172/jci.insight.207890
  10. BMC Urol. 2026 Aug 12. pii: 284. [Epub ahead of print]26(1):
      A 14-year-old female presented with intermittent left flank pain and was found to have a large renal mass on imaging. She exhibited clinical features suggestive of tuberous sclerosis complex (TSC), including facial angiofibromas and subependymal hamartomas on brain imaging. Contrast-enhanced CT of the abdomen revealed a heterogeneously enhancing renal mass without fat or calcification, raising suspicion for a non-angiomyolipomatous lesion. The patient underwent laparoscopic radical nephrectomy, and histopathology with immunohistochemistry confirmed the diagnosis of renal leiomyoma-a rare, benign mesenchymal tumor. This case underscores the importance of considering renal leiomyoma in the differential diagnosis of renal tumors in young patients with TSC and highlights the role of histopathological and immunohistochemical evaluation in establishing an accurate diagnosis and guiding management.
    Keywords:  Differential diagnosis; Immunohistochemistry; Pediatric renal tumor; Renal leiomyoma; Tuberous sclerosis complex
    DOI:  https://doi.org/10.1186/s12894-026-02309-9
  11. CNS Neurosci Ther. 2026 Nov;pii: e71262. [Epub ahead of print]32(11):
       BACKGROUND: Tuberous sclerosis complex (TSC) is characterized by developmental delay and intractable epilepsy, with multiple cortical tubers in the brain. However, the mechanism underlying epileptogenesis within these tubers remains unclear.
    METHODS: RNA sequencing (RNA-seq) analysis of resected human cortical tubers identified differential CD44 expression as a potential contributor to TSC epilepsy. By analyzing clinical characteristics, resected brain tissues, 18F-fludeoxyglucose PET images, cultured cortical neurons, and neocortical seizure animal models, the effect of CD44 on the epileptogenesis of cortical tubers was investigated.
    RESULTS: Increased CD44 expression was found in human Epi tubers compared with non-Epi tubers and closely correlated with the clinical characteristics of Epi tubers. CD44 activation increased neocortical seizure susceptibility and aggravated cortical pyramidal neuronal excitatory/inhibitory (E/I) imbalance. CASK was selected as the downstream target of CD44 using RNA-seq. Anti-CD44 monoclonal antibodies rescued the E/I imbalance in resected Epi tubers, and CD44 activation rescued the decreased firing frequency and increased action potential threshold induced by CASK inhibition. The CD44-CASK pathway exhibited diagnostic potential for identifying Epi tubers and predicting surgical outcomes via ROC analysis.
    CONCLUSION: CD44 activation predisposes cortical tubers to epileptogenesis, and could be a potential biomarker for identifying Epi tubers and predicting surgical outcomes in TSC patients.
    Keywords:  CD44; biomarker; cortical tubers; epileptogenesis; tuberous sclerosis complex
    DOI:  https://doi.org/10.1002/cns.71262
  12. Front Pharmacol. 2026 ;17 1976563
       Introduction: Breast cancer remains a leading cause of cancer-related morbidity and mortality worldwide, and effective, well-tolerated therapeutic strategies are needed. Berbamine (BBM), a natural bisbenzylisoquinoline alkaloid, has anticancer activity, but its effects on autophagy- and lysosome-related processes in breast cancer remain incompletely understood.
    Methods: We evaluated the effects of BBM on MDA-MB-231, MDA-MB-468, MCF-7, and 4T1 breast cancer cells and normal mammary epithelial cells using assays of cell viability, migration, invasion, autophagy-related responses, lysosome-associated changes, immunofluorescence, transmission electron microscopy, and Western blotting. Exploratory network analysis was used to prioritize candidate BBM-associated pathways, and molecular docking was used to predict interactions between BBM and selected pathway proteins. Antitumor activity was further assessed in an MCF-7 xenograft model.
    Results: BBM inhibited the proliferation, migration, and invasion of breast cancer cells while showing relatively low cytotoxicity toward normal mammary epithelial cells. BBM treatment was associated with increased levels of p-ULK1, ATG5, ATG7, and Beclin1, increased LC3 puncta, and accumulation of double-membraned autophagosomes. BBM was also associated with TFEB nuclear translocation, increased LAMP2 expression, and enhanced LysoTracker staining. Network analysis prioritized the PI3K/Akt signaling pathway, and molecular docking predicted potential interactions between BBM and PI3K, Akt1, and mTOR. Western blot analysis showed reduced phosphorylation of these proteins in cultured breast cancer cells. In the MCF-7 xenograft model, BBM inhibited tumor growth and was associated with changes in autophagy-related markers.
    Discussion: These findings support the involvement of autophagy-related responses, lysosome-associated changes, and PI3K/Akt1/mTOR pathway modulation in the anti-breast-cancer effects of BBM, while further studies are needed to establish direct target engagement and causal relationships.
    Keywords:  PI3K/AKT/mTOR; antitumor activity; autophagy; berbamine; breast cancer
    DOI:  https://doi.org/10.3389/fphar.2026.1976563
  13. Cell Death Differ. 2026 Nov 07.
      Purine homeostasis is essential for numerous cellular processes. Although purine metabolite accumulation occurs in various pathological and therapeutic contexts, the cellular consequences and underlying mechanisms remain poorly understood. In this study, we utilized gain-of-function mutations in phosphoribosylpyrophosphate synthetase 1 (PRPS1) as a model of intracellular purine accumulation and discovered that elevated purines-particularly deoxyguanosine (dG)-suppressed the mTORC1 signaling pathway. We identified elongation factor Tu (TUFM) as a novel regulator of RHEB by stabilizing its GTP/GDP binding. Accumulation of dG enhanced phosphorylation of RHEB at Ser130, triggering dissociation of both TUFM and guanine nucleotides from RHEB, thereby reducing RHEB activity and downstream mTORC1 signaling. Notably, similar suppression of mTORC1 and loss of TUFM binding were observed upon inhibition of xanthine dehydrogenase/oxidase, another condition associated with purine buildup. Together, these findings reveal a previously unrecognized regulatory crosstalk between purine metabolism and the mTORC1 pathway, mediated through the TUFM-RHEB axis.
    DOI:  https://doi.org/10.1038/s41418-026-01905-4
  14. Funct Integr Genomics. 2026 Nov 12. pii: 334. [Epub ahead of print]26(1):
      Cerebral ischemia/reperfusion (CI/R) injury is a neurological disorder in which microglia and macrophages regulate repair by switching M1/M2 phenotypes. RORα, a regulator of circadian rhythm and a mediator for melatonin effects, has an unclear role in CI/R injury and melatonin-mediated neuroprotection, particularly in microglial/macrophage polarization. An in vivo transient middle cerebral artery occlusion/reperfusion model was established in C57BL/6J mice, and in vitro oxygen-glucose deprivation/reoxygenation (OGD/R) models were developed for BV-2 and HT22 cells. In vivo, Flag-tagged RORα overexpression lentivirus were intracranially injected and melatonin (10 mg/kg) was injected intraperitoneally; in vitro, BV2 cells were exposed to 200 µM melatonin and infected with an RORα-overexpressing lentiviral vector, while HT22 cells were cultivated in conditioned medium. Western blot, immunofluorescence, TTC staining, and ELISA were used to evaluate RORα expression, neurological function, microglia/macrophage M2 polarization, inflammatory responses, and cellular apoptosis, respectively. The role of the AMPK-mTOR pathway was confirmed using the AMPK inhibitor Compound C in vitro. The viability, apoptosis, and ROS levels of HT22 cell were assessed using CCK-8 assay, TUNEL staining, and flow cytometry, respectively. In both in vivo and BV-2 cell in vitro models, RORα levels gradually decreased within 24 h, followed by a gradual recovery. Melatonin reduced neurological scores and enhanced blood-brain barrier protection, promoting M2 microglia/macrophage polarization and inhibiting subsequent inflammatory responses, with RORα overexpression further amplifying these effects. In an HT22 cell model, RORα overexpression enhanced the protection by melatonin against OGD/R-induced reductions in cell viability, as well as against increased apoptosis and elevated ROS levels. Mechanistically, RORα overexpression promoted M2 microglial polarization via activation of the AMPK-mTOR pathway, thereby amplifying the melatonin-mediated neuroprotection. RORα enhanced neuroprotection by melatonin against CI/R injury through promoting microglia/macrophage M2 polarization, suggesting a possible treatment target for CI/R injury.
    Keywords:  Cerebral ischemia/reperfusion (CI/R) injury; Melatonin; Microglia/macrophage M2 polarization; RORα
    DOI:  https://doi.org/10.1007/s10142-026-02119-0
  15. Transl Cancer Res. 2026 Oct 30. 15(10): 738
       Background: Hyperglycemia is an independent risk factor for poor prognosis in non-small cell lung cancer (NSCLC), yet the underlying metabolic-oncogenic crosstalk remains incompletely defined. The hexosamine biosynthetic pathway (HBP) senses glucose flux and generates UDP-GlcNAc for O-GlcNAcylation, a post-translational modification catalyzed by O-GlcNAc transferase (OGT). Here we investigate whether and how high glucose exploits OGT-mediated O-GlcNAcylation to fuel NSCLC malignancy.
    Methods: A549 and H1299 NSCLC cells were cultured in normal (5.5 mM) or high (25 mM) glucose. Proliferation, colony formation, migration, invasion, wound healing, and apoptosis were evaluated. OGT and global O-GlcNAc levels were assessed in tumor versus adjacent normal tissues by immunohistochemistry and in cells by western blotting. Stable OGT-knockdown (sh-OGT) lines were generated to dissect functional requirements. PI3K/AKT/mTOR pathway activation was examined by phospho-specific western blotting. The cell lines were tested and confirmed to be mycoplasma-free.
    Results: High glucose significantly enhanced proliferation, clonogenicity, migration, and invasion, and suppressed apoptosis by downregulating Bax and upregulating Bcl-2. OGT and global O-GlcNAcylation were markedly upregulated in NSCLC tissues and in high-glucose-treated cells. OGT silencing abrogated high-glucose-induced malignant phenotypes, restored apoptotic sensitivity, and reverted the Bax/Bcl-2 ratio. Mechanistically, high-glucose-driven O-GlcNAcylation activated PI3K, AKT, and mTOR phosphorylation, whereas OGT knockdown blunted this activation.
    Conclusions: OGT-orchestrated hyper-O-GlcNAcylation is a pivotal conduit linking the hyperglycemic microenvironment to PI3K/AKT/mTOR-dependent NSCLC progression. Targeting OGT-mediated O-GlcNAcylation may offer a precision therapeutic strategy for NSCLC patients with comorbid diabetes or hyperglycemia.
    Keywords:  Non-small cell lung cancer (NSCLC); O-GlcNAc transferase (OGT); O-GlcNAcylation; PI3K/AKT/mTOR pathway; hyperglycemia
    DOI:  https://doi.org/10.21037/tcr-2026-2076
  16. Int J Mol Sci. 2026 Oct 30. pii: 9773. [Epub ahead of print]27(21):
      Incomplete penetrance and variable expressivity complicate interpretation of germline GATOR1 variants and individual-level phenotype prediction. We conducted a family-based systematic review and meta-analysis, reconstructing individual-level data from published pedigrees and reassessing variants using GATOR1-specific classification criteria. Sixty-three studies were included; 59 contributed 734 individuals heterozygous for germline pathogenic or likely pathogenic (P/LP) variants from 227 families. The pooled proportion of affected individuals was 65.7%. Recurrent variant status, variant consequence, DEPDC5 protein domain, transmitting-parent phenotype, and overall parental origin did not consistently distinguish affected from unaffected individuals, although paternal DEPDC5 transmission showed an exploratory association with higher disease expression (90.4% vs. 82.4%, p = 0.032). Among affected individuals, missense variants were associated with earlier seizure onset than loss-of-function (LoF) variants (0.67 vs. 4.50 years, p = 0.002). LoF variants in the DEPDC5 LassoA domain showed exploratory associations with cognitive impairment, MRI abnormalities, and epilepsy surgery (FDR-adjusted p ≤ 0.046). An expanded synthesis identified 14 published same-gene germline-somatic second-hit cases, of which 85.7% had focal cortical dysplasia (FCD) IIa; quantifiable somatic variant allele fractions (VAFs) for sequence-variant second hits were below 5% in all six single-region cases, whereas multiregion sampling in three cases showed spatial variation, including values below 1%. These findings suggest that disease expression and post-onset phenotype represent partly distinct aspects of clinical heterogeneity in GATOR1-related epilepsy.
    Keywords:  GATOR1; epilepsy; familial transmission; genotype–phenotype correlation; somatic second hit; variable expressivity
    DOI:  https://doi.org/10.3390/ijms27219773
  17. Biology (Basel). 2026 Nov 02. pii: 1976. [Epub ahead of print]15(21):
       BACKGROUND: Tuberous sclerosis complex (TSC) frequently causes epilepsy, but cell-type-specific molecular alterations in human lesions remain incompletely understood.
    METHODS: We performed single-nucleus RNA sequencing of cortical tissue from three TSC and three surgical control donors, with single-nucleus chromatin accessibility profiling in two donors per group from the same cohort. Donor-level pseudobulk differential analyses were combined with functional enrichment, inferred cell communication, and motif analyses.
    RESULTS: Among the six cell types displayed in the main comparison, microglia had the most differentially expressed genes (872; 282 upregulated and 590 downregulated). Downregulated genes were enriched for lysosomal and lipid-storage processes. Inferred APP-CD74 input to microglia was higher for most source cell types, whereas APP-SORL1 changes varied by source. Chromatin analysis identified 9283 differentially accessible regions. Predicted regions linked to ABCA1, ATP6V0A1, and GPNMB showed decreased accessibility, concordant with lower RNA expression. Donor-averaged TFEB- and TFE3-associated chromatin variation across regions (chromVAR) scores were lower in TSC.
    CONCLUSIONS: These exploratory findings suggest microglial remodeling involving lysosomal and lipid-storage processes. It may provide a molecular basis for further investigation of microglia in epileptogenesis.
    Keywords:  epilepsy; lipid transport; lysosome; microglia; single-nucleus ATAC sequencing; single-nucleus RNA sequencing; tuberous sclerosis complex
    DOI:  https://doi.org/10.3390/biology15211976